hepatitis C

U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C meds
Fierce Pharma
Tue, 05/9/17 - 10:43 pm
JNJ
drug manufacturing
immunology
hepatitis C
Remicade
Simponi
Stelara
Olysio
3 Things to Watch With Gilead Sciences, Inc. Q1 Results
Motley Fool
Sun, 04/30/17 - 12:52 pm
Gilead Sciences
earnings
hepatitis C
Genvoya
R&D
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Marketwatch
Fri, 04/28/17 - 10:32 am
Bristol-Myers Squibb
China
hepatitis C
Daklinza
AbbVie, Enanta post stellar hep C PhIII data, but no one is cheering
Endpoints
Thu, 04/20/17 - 08:52 pm
AbbVie
Enanta
hepatitis C
glecaprevir/pibrentasvir
Gilead works on lifecycle management for Sovaldi as Hep C franchise wanes
BioPharma Dive
Thu, 04/13/17 - 11:48 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead Hep C Drugs Get Supplemental FDA Nod
Investopedia
Sat, 04/8/17 - 01:11 pm
Gilead Sciences
hepatitis C
FDA
Harvoni
Sovaldi
The Worst-Case Scenario for Gilead Sciences, Inc.
Motley Fool
Sat, 04/1/17 - 08:06 am
Gilead Sciences
M&A
hepatitis C
HIV
Should the US government license hep C drugs?
BioPharma Dive
Fri, 03/31/17 - 09:55 pm
hepatitis C
Merck
Gilead Sciences
Gilead's Harvoni ads go from before to after with new creative focused on hep C cure
Fierce Pharma
Wed, 03/29/17 - 10:40 pm
Gilead Sciences
Harvoni
drug ads
DTC ads
hepatitis C
Gilead hepatitis C drug patent faces European challenge
Yahoo/Reuters
Mon, 03/27/17 - 09:47 am
Gilead Sciences
hepatitis C
Europe
sofosbuvir
AbbVie's Hepatitis C Treatment Under Priority Review in Japan
Yahoo/GuruFocus
Wed, 03/15/17 - 09:47 pm
AbbVie
hepatitis C
Japan
glecaprevir/pibrentasvir
What Does Gilead Need? Stable HCV Scripts and “a String of Pearls”
Barron's
Fri, 03/10/17 - 09:52 am
Gilead Sciences
hepatitis C
Here's Why the Best Is Yet to Come for Gilead Sciences, Inc.
Motley Fool
Tue, 03/7/17 - 11:17 am
Gilead Sciences
HIV
hepatitis C
Merck to take $2.9 billion charge on hepatitis C drug
Marketwatch
Thu, 02/23/17 - 09:28 pm
Merck
hepatitis C
uprifosbuvir
Gilead pushes hep C testing in baby boomers as its blockbusters plummet
Fierce Pharma
Thu, 02/23/17 - 09:21 am
Gilead Sciences
hepatitis C
baby boomers
DTC advertising
Harvoni
Sovaldi
3 Things Gilead Sciences' CEO Just Said That You'll Want to Know
Motley Fool
Wed, 02/22/17 - 05:10 pm
Gilead Sciences
Pharma CEOs
John Milligan
hepatitis C
HIV
M&A
Gilead cured hepatitis C. That’s become its biggest problem
Marketwatch
Wed, 02/8/17 - 09:27 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Bloomberg
Wed, 02/8/17 - 09:21 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
U.S. FDA Grants Priority Review to AbbVie for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
Yahoo
Thu, 02/2/17 - 09:22 am
FDA
AbbVie
glecaprevir/pibrentasvir
G/P
hepatitis C
Regulus Hep C Drug Stays On Clinical Hold
Investopedia
Wed, 02/1/17 - 09:37 am
Regulus
hepatitis C
RG-101

Pages